Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report

Astrid E Persson

Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report

Skåne University Hospital

Research output: Other contribution › Web publication/Blog post › Research

Original language	English
Publisher	European Society for Radiotherapy and Oncology (ESTRO)
Publication status	Published - 2024 Jul 10

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://www.estro.org/About/Newsroom/Newsletter/Congresses/CtRO-Young-Researcher-AwardLicence: Unspecified

1 Abstract

Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
Persson, A. E., Kjellén, E., Garmo, H., Adrian, G., Stattin, P., Widmark, A., Nilsson, P. & Gunnlaugsson, A., 2024 May 3, p. S2287-S2291. 4 p.
Research output: Contribution to conference › Abstract › peer-review

Open Access

1 Participation in conference

ESTRO 2024
Persson, A. (Presenter)
2024 May 3 → 2024 May 7
Activity: Participating in or organising an event › Participation in conference

Young Researcher Award
Persson, A. (Recipient), 2024 May 6
Prize: Prize (including medals and awards)

Cite this

Persson, A. E. (2024, Jul 10). Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report. European Society for Radiotherapy and Oncology (ESTRO). https://www.estro.org/About/Newsroom/Newsletter/Congresses/CtRO-Young-Researcher-Award

@misc{89d468fc4d4b4818989b0d3e1546ddde,

title = "Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report",

author = "Persson, {Astrid E}",

year = "2024",

month = jul,

day = "10",

language = "English",

publisher = "European Society for Radiotherapy and Oncology (ESTRO)",

type = "Other",

}

Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report

Subject classification (UKÄ)

UN SDGs

Access to Document

Research output

Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial

Activities

ESTRO 2024

Prizes

Young Researcher Award

Cite this